FDA Inspection
Teva Pharmaceutical Industries Ltd.Teva Pharmaceutical Industries Ltd. – FDA Inspection, May 25, 2017
Record Details
This FDA Inspection record concerns Teva Pharmaceutical Industries Ltd., with an inspection on May 25, 2017, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 4053c2de-9a99-4a78-8140-362ab3f99d8a
Inspection Facts
- Inspection number
- 1016187
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Teva Pharmaceutical Industries Ltd.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| May 23, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 22, 2019 | Not classified | Office of Inspections and Investigations | |
| July 25, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 15, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 18, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Teva Pharmaceutical Industries Ltd.
- FDA Inspection 1207104 - 2023-05-23
- FDA Inspection 1111726 - 2019-09-22
- FDA Inspection 1099394 - 2019-07-25
- FDA Inspection 935223 - 2015-06-15
- FDA Inspection 849301 - 2013-07-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.